Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

2.2K
The goal of this method paper is to demonstrate a robust and reproducible methodology for the enrichment, generation, and expansion of primary tumor cell lines from surgically resected pleural mesothelioma.
2.2K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

7.5K
Transgenic lck:eGFP zebrafish express GFP highly in T lymphocytes, and have been used to study T cell development and acute lymphoblastic leukemia. This line can be used to study B cells, which express lck at lower levels. This protocol describes purification of malignant and non-malignant B cells from lck:eGFP...
7.5K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

7.3K
This article describes the generation of an orthotopic mouse model of human pleural mesothelioma by implantation of H2052/484 mesothelioma cells into the pleural cavity of immunocompromised athymic mice. The longitudinal monitoring of the development of intrapleural tumors was assessed by non-invasive multimodal [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography...
7.3K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

759
This study introduces multifractal spectrum analysis for assessing pulmonary nodule malignancy. Using CT-DICOM data, the method calculates fractal dimensions across multiple voxel scales, revealing significant differences between early-stage and late-stage pulmonary...
759
Global Climate Change01:50

Global Climate Change

28.7K
Throughout its ~4.5 billion year history, the Earth has experienced periods of warming and cooling. However, the current drastic increase in global temperatures is well outside of the Earth’s cyclic norms, and evidence for human-caused global climate change is compelling. Paleoclimatology, the study of ancient climate conditions, provides ample evidence for human-caused global climate change by comparing recent conditions with those in the past.
28.7K
Work Done During Volume Change01:17

Work Done During Volume Change

5.1K
In mechanics, work is done on an object when the force acting on it displaces the object. In thermodynamics, work done on a system can be estimated when the system's volume changes during any thermodynamic process.
Consider a gas confined to a cylinder fitted with a movable piston at one end. If the gas expands from volume V1 to volume V2, it exerts a force on the piston, such that the piston moves by a distance dr.
The work done by the gas on the piston can be expressed as
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Theoretical Clinical Utility of Advanced Practice Provider Use of an Artificial Intelligence Radiomics-based Tool for Pulmonary Nodule Evaluation and Management.

CHEST pulmonary·2026
Same author

Lung Cancer Yield by Baseline Screening Lung CT Screening Reporting and Data System (Lung-RADS) Assignment and Patient Factors: The Population-Based Research to Optimize the Screening Process Lung Consortium.

CHEST pulmonary·2026
Same author

The role of pulsed electric field therapy in non-small cell lung cancer: a narrative review of a novel minimally invasive intervention.

Journal of thoracic disease·2026
Same author

Defining the abscopal effect in non-small cell lung cancer in the era of immunotherapy and lung ablation treatment: a narrative review.

Frontiers in medicine·2026
Same author

Tumor draining lymph nodes in non-small cell lung cancer: <i>underrecognized role in biomarker discovery and therapeutic innovation</i>.

Frontiers in immunology·2026
Same author

The role of bronchoscopic cryoimmunotherapy in non-small cell lung cancer: current evidence and future perspectives.

Immunotherapy·2026

Related Experiment Video

Updated: Jan 19, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.2K

Malignant Mesothelioma: Has Anything Changed?

Roger Y Kim1, Daniel H Sterman2, Andrew R Haas3

  • 1Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Seminars in Respiratory and Critical Care Medicine
|September 17, 2019
PubMed
Summary
This summary is machine-generated.

Malignant pleural mesothelioma, a rare asbestos-linked cancer, has seen improved diagnosis and chemotherapy since 2003. Future breakthroughs in immunotherapy offer hope for better mesothelioma treatment outcomes.

More Related Videos

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K

Related Experiment Videos

Last Updated: Jan 19, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.2K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K

Area of Science:

  • Oncology
  • Pulmonary Medicine
  • Environmental Health

Background:

  • Malignant pleural mesothelioma is a rare, aggressive cancer linked to asbestos exposure.
  • Current treatment options are limited and often noncurative, with a poor prognosis.
  • Global incidence is rising, necessitating advancements in patient care.

Purpose of the Study:

  • To review the current clinical strategies for diagnosing malignant pleural mesothelioma.
  • To outline contemporary staging methodologies for this rare cancer.
  • To summarize existing and emerging treatment modalities for malignant pleural mesothelioma.

Main Methods:

  • Literature review of recent advancements in mesothelioma diagnosis and staging.
  • Analysis of established and novel therapeutic approaches, including chemotherapy and immunotherapy.
  • Synthesis of current clinical guidelines and expert consensus on multimodal therapy.

Main Results:

  • Improved understanding of mesothelioma pathophysiology has enhanced diagnostic accuracy and staging.
  • The pemetrexed/platin chemotherapy regimen, established in 2003, remains a standard first-line treatment.
  • Immunotherapy presents a promising avenue for future treatment paradigms.

Conclusions:

  • Accurate diagnosis and staging are crucial for effective malignant pleural mesothelioma management.
  • Multimodal therapy, incorporating surgery, radiation, and chemotherapy, is standard, though optimal sequencing is debated.
  • Emerging immunotherapies hold significant potential to improve outcomes for mesothelioma patients.